000142928 001__ 142928
000142928 005__ 20240303003700.0
000142928 0247_ $$2doi$$a10.1186/s12879-019-3691-2
000142928 0247_ $$2pmid$$apmid:30700258
000142928 0247_ $$2pmc$$apmc:PMC6354372
000142928 0247_ $$2altmetric$$aaltmetric:60555634
000142928 037__ $$aDKFZ-2019-00556
000142928 041__ $$aeng
000142928 082__ $$a610
000142928 1001_ $$aCaputo, Mahrrouz$$b0
000142928 245__ $$aHerpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort.
000142928 260__ $$aHeidelberg$$bSpringer$$c2019
000142928 3367_ $$2DRIVER$$aarticle
000142928 3367_ $$2DataCite$$aOutput Types/Journal article
000142928 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1551359767_7024
000142928 3367_ $$2BibTeX$$aARTICLE
000142928 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142928 3367_ $$00$$2EndNote$$aJournal Article
000142928 520__ $$aUntil now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complication postherpetic neuralgia (PHN) using data from the pretest studies of the German National Cohort (GNC) in comparison with estimates based on health insurance data.Data of 4751 participants aged between 20 and 69 years from two pretest studies of the GNC carried out in 2011 and 2012 were used. Based on self-reports of physician-diagnosed HZ and PHN, age- and sex-specific HZ incidence rates and PHN proportions were estimated. For comparison, estimates based on statutory health insurance data from the German population were considered.Eleven percent (95%-CI, 10.4 to 12.3, n = 539) of the participants reported at least one HZ episode in their lifetime. Our estimated age-specific HZ incidence rates were lower than previous estimates based on statutory health insurance data. The PHN proportion in participants older than 50 years was 5.9% (1.9 to 13.9%), which was in line with estimates based on health insurance data.As age- and sex-specific patterns were comparable with that in health insurance data, self-reported diagnosis of HZ seems to be a valid instrument for overall disease trends. Possible reasons for observed differences in incidence rates are recall bias in self-reported data or overestimation in health insurance data.
000142928 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142928 588__ $$aDataset connected to CrossRef, PubMed,
000142928 7001_ $$aHorn, Johannes$$b1
000142928 7001_ $$aKarch, André$$b2
000142928 7001_ $$aAkmatov, Manas K$$b3
000142928 7001_ $$aBecher, Heiko$$b4
000142928 7001_ $$aBraun, Bettina$$b5
000142928 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b6$$udkfz
000142928 7001_ $$aCastell, Stefanie$$b7
000142928 7001_ $$aFischer, Beate$$b8
000142928 7001_ $$aGiani, Guido$$b9
000142928 7001_ $$aGünther, Kathrin$$b10
000142928 7001_ $$aHoffmann, Barbara$$b11
000142928 7001_ $$aJöckel, Karl-Heinz$$b12
000142928 7001_ $$aKeil, Thomas$$b13
000142928 7001_ $$aKlüppelholz, Birgit$$b14
000142928 7001_ $$aKrist, Lilian$$b15
000142928 7001_ $$aLeitzmann, Michael F$$b16
000142928 7001_ $$aLieb, Wolfgang$$b17
000142928 7001_ $$aLinseisen, Jakob$$b18
000142928 7001_ $$aMeisinger, Christa$$b19
000142928 7001_ $$aMoebus, Susanne$$b20
000142928 7001_ $$aObi, Nadia$$b21
000142928 7001_ $$aPischon, Tobias$$b22
000142928 7001_ $$aSchipf, Sabine$$b23
000142928 7001_ $$aSchmidt, Börge$$b24
000142928 7001_ $$aSievers, Claudia$$b25
000142928 7001_ $$aSteinbrecher, Astrid$$b26
000142928 7001_ $$aVölzke, Henry$$b27
000142928 7001_ $$aMikolajczyk, Rafael$$b28
000142928 773__ $$0PERI:(DE-600)2041550-3$$a10.1186/s12879-019-3691-2$$gVol. 19, no. 1, p. 99$$n1$$p99$$tBMC infectious diseases$$v19$$x1471-2334$$y2019
000142928 909CO $$ooai:inrepo02.dkfz.de:142928$$pVDB
000142928 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000142928 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142928 9141_ $$y2019
000142928 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC INFECT DIS : 2017
000142928 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142928 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142928 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142928 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000142928 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000142928 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000142928 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review
000142928 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000142928 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000142928 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000142928 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142928 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142928 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142928 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142928 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000142928 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000142928 980__ $$ajournal
000142928 980__ $$aVDB
000142928 980__ $$aI:(DE-He78)C070-20160331
000142928 980__ $$aI:(DE-He78)C120-20160331
000142928 980__ $$aUNRESTRICTED